Women’s Issues With Hepatitis C - Side Effect Management

[Guest guest]

For the ladies! - I ran across this and it looked very helpful:

Women’s Issues With Hepatitis C - Side Effect Management

Hepatitis C (HCV) affects women differently than men. Women, especially if they were young at the time of acquiring the virus, are less likely than men to progress from acute to chronic HCV. Thus, women have a higher rate of spontaneous viral clearance than men. And, women, especially premenopausal women, appear to progress to cirrhosis less often then men. In fact, studies have shown that women with HCV have only a 5 percent likelihood of progressing to cirrhosis, as compared with a 20-30 percent likelihood for men. In addition, many studies have found that men are as much as four times more likely than women to develop liver cancer due to HCV. Finally, women appear to be better responders to therapy with pegylated interferon plus ribavirin. Thus, women with HCV are cured a greater percentage of the time than men. While these differences between men and women are well documented, many issues pertaining specifically to women undergoing therapy for HCV have not been extensively studied.

Overall, women on pegylated interferon plus ribavirin experience side effects more frequently than men. Women more frequently suffer from fatigue, headaches, depression, anxiety, irritability and insomnia. However, in this article, I will concentrate on some cosmetic concerns, sexual problems, menstrual irregularities, and bone loss problems that women with HCV may encounter while on antiviral therapy. I will also discuss some helpful ways to diminish these potential side effects or to prevent them from occurring in the first place.

http://www.liverdisease.com/womenhcv.html

Chris

Create a Home Theater Like the Pros. Watch the video on AOL Home.

[Guest guest]

Very interesting article,, not sure where they got their facts from,, smalk50@... wrote: For the ladies! - I ran across this and it looked very helpful: Women’s Issues With Hepatitis C - Side Effect Management Hepatitis C (HCV) affects women differently than men. Women, especially if they were young at the time of acquiring the virus, are less likely than men to progress from acute

to chronic HCV. Thus, women have a higher rate of spontaneous viral clearance than men. And, women, especially premenopausal women, appear to progress to cirrhosis less often then men. In fact, studies have shown that women with HCV have only a 5 percent likelihood of progressing to cirrhosis, as compared with a 20-30 percent likelihood for men. In addition, many studies have found that men are as much as four times more likely than women to develop liver cancer due to HCV. Finally, women appear to be better responders to therapy with pegylated interferon plus ribavirin. Thus, women with HCV are cured a greater percentage of the time than men. While these differences between men and women are well documented, many issues pertaining specifically to women undergoing therapy for HCV have not been extensively studied. Overall, women on pegylated interferon plus ribavirin experience side effects more frequently than

men. Women more frequently suffer from fatigue, headaches, depression, anxiety, irritability and insomnia. However, in this article, I will concentrate on some cosmetic concerns, sexual problems, menstrual irregularities, and bone loss problems that women with HCV may encounter while on antiviral therapy. I will also discuss some helpful ways to diminish these potential side effects or to prevent them from occurring in the first place. http://www.liverdisease.com/womenhcv.html Create a Home Theater Like the Pros. Watch the video on AOL Home. Jackie

[Guest guest]

Facts came from: Palmer, MD is the author of " Dr. Palmer's Guide of Hepatitis and Liver Disease". (Published 2004. Penguin Putnam).Jackie on wrote: Very interesting article,, not sure where they got their facts from,, smalk50aol wrote:

For the ladies! - I ran across this and it looked very helpful: Women’s Issues With Hepatitis C - Side Effect Management Hepatitis C (HCV) affects women differently than men. Women, especially if they were young at the time of acquiring the virus, are less likely than men to progress from acute to chronic HCV. Thus, women have a higher rate of spontaneous viral clearance than men. And, women, especially premenopausal women, appear to progress to cirrhosis less often then men. In fact, studies have shown that women with HCV have only a 5 percent likelihood of progressing to cirrhosis, as compared with a 20-30 percent likelihood for men. In addition, many studies have found that men are as much as four times more likely than women to develop liver cancer due to HCV. Finally, women appear to be better

responders to therapy with pegylated interferon plus ribavirin. Thus, women with HCV are cured a greater percentage of the time than men. While these differences between men and women are well documented, many issues pertaining specifically to women undergoing therapy for HCV have not been extensively studied. Overall, women on pegylated interferon plus ribavirin experience side effects more frequently than men. Women more frequently suffer from fatigue, headaches, depression, anxiety, irritability and insomnia. However, in this article, I will concentrate on some cosmetic concerns, sexual problems, menstrual irregularities, and bone loss problems that women with HCV may encounter while on antiviral therapy. I will also discuss some helpful ways to diminish these potential side effects or to prevent them from occurring in the first place. http://www.liverdisease.com/womenhcv.html Create a Home Theater Like the Pros. Watch the video on AOL Home. Jackie

Never miss a thing. Make Yahoo your homepage.

[Guest guest]

Facts came from: Palmer, MD is the author of " Dr. Palmer's Guide of Hepatitis and Liver Disease". (Published 2004. Penguin Putnam).Jackie on wrote: Very interesting article,, not sure where they got their facts from,, smalk50aol wrote:

For the ladies! - I ran across this and it looked very helpful: Women’s Issues With Hepatitis C - Side Effect Management Hepatitis C (HCV) affects women differently than men. Women, especially if they were young at the time of acquiring the virus, are less likely than men to progress from acute to chronic HCV. Thus, women have a higher rate of spontaneous viral clearance than men. And, women, especially premenopausal women, appear to progress to cirrhosis less often then men. In fact, studies have shown that women with HCV have only a 5 percent likelihood of progressing to cirrhosis, as compared with a 20-30 percent likelihood for men. In addition, many studies have found that men are as much as four times more likely than women to develop liver cancer due to HCV. Finally, women appear to be better

responders to therapy with pegylated interferon plus ribavirin. Thus, women with HCV are cured a greater percentage of the time than men. While these differences between men and women are well documented, many issues pertaining specifically to women undergoing therapy for HCV have not been extensively studied. Overall, women on pegylated interferon plus ribavirin experience side effects more frequently than men. Women more frequently suffer from fatigue, headaches, depression, anxiety, irritability and insomnia. However, in this article, I will concentrate on some cosmetic concerns, sexual problems, menstrual irregularities, and bone loss problems that women with HCV may encounter while on antiviral therapy. I will also discuss some helpful ways to diminish these potential side effects or to prevent them from occurring in the first place. http://www.liverdisease.com/womenhcv.html Create a Home Theater Like the Pros. Watch the video on AOL Home. Jackie

Never miss a thing. Make Yahoo your homepage.